» Articles » PMID: 30042601

Satisfaction and Discontent of Polish Patients with Biological Therapy of Rheumatic Diseases: Results of a Multi-center Questionnaire Study

Abstract

Objectives: Biologics are medications widely applied in the management of inflammatory rheumatic diseases. The drugs were found to be effective but their application is associated with some disadvantages. Medication with biologics is relatively expensive, and in Poland, it is carried out in specialized centers. The study was designed to evaluate various aspects of satisfaction and dissatisfaction of Polish patients treated with biologics.

Material And Methods: An anonymous questionnaire was distributed in 23 Polish rheumatological centers involved in the treatment; 1212 returned questionnaires were used for analysis. Responses were received from 606 patients with rheumatoid arthritis, 427 with ankylosing spondylitis, 117 psoriatic arthritis, and 62 adult patients with juvenile idiopathic arthritis (in whom administration of the drugs had been introduced before they were 18 years old). The investigated group constituted about one-fifth of all rheumatic patients on biologics in Poland.

Results: A beneficial or very beneficial influence of the medication on the state of physical health was found mostly in patients with rheumatoid arthritis (51.3 and 30.5%) and ankylosing spondylitis (51.0 and 36.8%). Family life was improved by the treatment especially in patients with ankylosing spondylitis (40.7 and 35.6% beneficial and very beneficial, respectively), sleep quality and sexual life mostly in those with ankylosing spondylitis (beneficial/very beneficial influence 41.5/38.4, and 38.7/23.9, respectively). There was a rather small influence of biological treatment on the financial situation of the patients. In general, satisfaction with the treatment was evaluated as positive or very positive in 88% of all investigated patients.In a significant part of the patients, transportation to the medical center was considered as a disadvantage of the treatment. About one-third of the patients considered laboratory and imaging tests to be done before initiation of the medication as a difficulty, and for about 40% waiting time for qualification for the medication was a significant disadvantage. The route of drug administration was without importance for 4/5 of the patients.

Conclusions: Summing up, the results were similar in the patients suffering from various diseases although those with psoriatic arthritis felt the highest satisfaction (possibly due to the positive aesthetic effect), and those with ankylosing spondylitis had significant improvement in sexual life (probably due to younger age). Relatively low satisfaction was found in patients with juvenile idiopathic arthritis. There was a small influence of medication on financial status of the patients. Application of biologics has few disadvantages and most of them are associated with the organization of health services (waiting time for the tests, transportation to the medical centers).

Citing Articles

Burden of disease, pain catastrophizing, and central sensitization in relation to work-related issues in young spondyloarthritis patients.

Ben Tekaya A, Ben Said H, Yousfi I, Ben Dhia S, Bouden S, Rouached L Reumatologia. 2024; 62(1):35-42.

PMID: 38558896 PMC: 10979370. DOI: 10.5114/reum/185390.


Sleep Problems in Patients With Psoriatic Arthritis: A Systematic Literature Review and Metaanalysis.

Grant C, Woodbury M, Skougaard M, Boldsen J, Ogdie A, Klerman E J Rheumatol. 2023; .

PMID: 37127321 PMC: 10618413. DOI: 10.3899/jrheum.2022-1169.


Influence of Disease Acceptance on the Quality of Life of Patients with Ankylosing Spondylitis - Single Centre Study.

Wysocki G, Czapla M, Uchmanowicz B, Fehler P, Aleksandrowicz K, Rypicz L Patient Prefer Adherence. 2023; 17:1075-1092.

PMID: 37090183 PMC: 10119491. DOI: 10.2147/PPA.S403437.


Perceived treatment satisfaction in patients with systemic rheumatic diseases treated with biologic therapies: results of a self-reported survey.

Ermeidis C, Dimitroulas T, Pourzitaki C, Voulgari P, Kouvelas D Rheumatol Int. 2023; 43(6):1151-1159.

PMID: 36786872 PMC: 9925926. DOI: 10.1007/s00296-023-05280-y.


Identifying Patient Access Barriers for Tumor Necrosis Factor Alpha Inhibitor Treatments in Rheumatoid Arthritis in Five Central Eastern European Countries.

Inotai A, Tomek D, Niewada M, Lorenzovici L, Kolek M, Weber J Front Pharmacol. 2020; 11:845.

PMID: 32581804 PMC: 7291365. DOI: 10.3389/fphar.2020.00845.

References
1.
van Genderen S, Plasqui G, van der Heijde D, van Gaalen F, Heuft L, Luime J . Social Role Participation and Satisfaction With Life: A Study Among Patients With Ankylosing Spondylitis and Population Controls. Arthritis Care Res (Hoboken). 2017; 70(4):600-607. DOI: 10.1002/acr.23304. View

2.
Gonzalez C, Carmona L, de Toro J, Batlle-Gualda E, Torralba A, Arteaga M . Perceptions of patients with rheumatic diseases on the impact on daily life and satisfaction with their medications: RHEU-LIFE, a survey to patients treated with subcutaneous biological products. Patient Prefer Adherence. 2017; 11:1243-1252. PMC: 5530861. DOI: 10.2147/PPA.S137052. View

3.
Liu Y, Dong H, Chen Z, Wang Y, Tu S . Impact of ankylosing spondylitis on sexual function: A systematic review and meta-analysis. Exp Ther Med. 2015; 9(4):1501-1507. PMC: 4353774. DOI: 10.3892/etm.2015.2239. View

4.
Uthman I, Noureldine M, Arayssi T, Chalhoub N, Akl E . How to treat ankylosing spondylitis and nonradiographic axial spondyloarthritis. Key practical messages from the 2015 American College of Rheumatology recommendations. Pol Arch Med Wewn. 2016; 126(4):254-61. DOI: 10.20452/pamw.3337. View

5.
Fan D, Liu L, Ding N, Liu S, Hu Y, Cai G . Male sexual dysfunction and ankylosing spondylitis: a systematic review and metaanalysis. J Rheumatol. 2014; 42(2):252-7. DOI: 10.3899/jrheum.140416. View